# Retrophin, Inc. — Form D

Retrophin, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-07. The offering totals $24.9M, of which $24.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-10-07
- Form: D
- Accession: 0001193805-13-001792
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.9M
- Amount sold: $24.9M
- Investors: 40
- Date of first sale: 2013-08-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-204142

## Issuer

- Name: Retrophin, Inc.
- CIK: 0001438533
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 777 THIRD AVENUE 22ND FLOOR, NEW YORK, NY, 10017
- Phone: 646-837-5863

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Stephen Aselage | Director | Newton, MA |
| Steve Richardson | Director | New York, NY |
| MARTIN SHKRELI | Director | NEW YORK, NY |
| Marc Panoff | Executive Officer | New York, NY |
| Horacio Plotkin | Executive Officer | New York, NY |
| MARTIN SHKRELI | Executive Officer | NEW YORK, NY |

## More

- [CIK 1438533 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1438533&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001193805-13-001792.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.